Stock Events

Stock Events

Abcam

0

0

+€0.00+0% 00:00 Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

Sep 25

€0.30

Jun 25

€0.26

Mar 25

€0.29

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Thermo Fisher Scientific

Thermo Fisher Scientific offers a wide range of research and diagnostic solutions, directly competing with Abcam's product offerings in antibodies and reagents.

Danaher, through its subsidiaries like Cytiva and Pall Corporation, provides similar life sciences tools and consumables, competing in the biotechnology and research sectors.

Illumina provides genomic sequencing solutions that are essential for research, competing with Abcam's offerings in the genomics and proteomics space.

Agilent Technologies

Agilent Technologies offers a broad range of analytical instruments and reagents, directly competing with Abcam in the life sciences and diagnostics markets.

Bio-Rad Laboratories

Bio-Rad Laboratories provides a variety of research and clinical diagnostic products that overlap with Abcam's portfolio, especially in antibody-based technologies.

Repligen offers bioprocessing technologies and products that support the development of biologic drugs, competing with Abcam's solutions for drug discovery and development.

Bio-Techne operates in similar markets as Abcam, offering reagents, instruments, and custom manufacturing services for research and diagnostic applications.

Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in areas similar to Abcam's.

Mettler-Toledo International

Mettler-Toledo International offers precision instruments and services for research and development, competing with Abcam in the provision of lab equipment and supplies.

Waters Corporation specializes in analytical laboratory instrument and software, competing with Abcam in the life sciences sector, particularly in chromatography and mass spectrometry.

About

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Show more...

CEO

Mr. Markus Lusser

Employees

1760

Country

United Kingdom

ISIN

US0003802040

Listings

0 Comments

Share your thoughts

FAQ

What is Abcam stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Abcam stocks are traded under the ticker A8C3.MU.

Does Abcam pay dividends?▼

Yes, A8C3.MU dividends are paid quarterly. The last dividend per share was 0.3 EUR. As of today, Dividend Yield (FWD)% is 0%.

How many employees does Abcam have?▼

As of July 21, 2026, the company has 1,760 employees.

In which sector is Abcam located?▼

Abcam operates in the Health & Wellness sector.

When did Abcam complete a stock split?▼

Abcam has not had any recent stock splits.

Where is Abcam headquartered?▼

Abcam is headquartered in Cambridge, United Kingdom.